Transgender and gender diverse persons’ sexually transmitted infection testing: a mixed methods study to understand primary care providers’ training gaps and desires to promote sexual health equity Authors: Ashley Lacombe-Duncan, Seema Mehta, Shanna K Kattari, Rory P O’Brien, Hadas Kluger, Julie Blaszczak Published: 2026 ABSTRACT AbstractBackgroundTransgender (trans) and gender diverse (TGD) people experience sexual health inequities, including high rates of HIV and other sexually transmitted infections (STIs), driven by anti-trans stigma. Yet, TGD people also face barriers to STI testing related to anti-trans stigma, including a lack of access to knowledgeable and affirming primary care providers (PCPs), including physicians, nurse practitioners, and physician assistants. We sought to understand the current practices, comfort, and knowledge gaps of PCPs in performing gender-affirming STI testing, particularly non-HIV STI testing, among TGD persons, in order to inform future educational interventions.MethodsWe utilized a convergent parallel mixed-methods study design drawing on cross-sectional quantitative surveys (n = 50) and semi-structured qualitative interviews (n = 8) with PCPs (2024–2025). The survey assessed sociodemographic and practice-related characteristics, past training, knowledge of STI testing guidelines, and TGD-related attitudes/biases. Interviews explored how PCPs apply STI testing guidelines and navigate sexual history taking/physical exam among TGD persons. Quantitative data were analyzed using bivariable and multivariable regression analyses to determine factors independently associated with self-reported clinical competency to assess a TGD person. Qualitative data were analyzed using open inductive coding via directed qualitative content analysis.ResultsAmong survey participants (mean age: 38.7, SD: 10.8), almost half (46%) had ≤ 5 h of training on any topic specific to TGD health. PCPs’ most desired future training topics included gender-affirming sexual history taking (62%), basic trans healthcare (e.g., gender-affirming hormone therapy [60%]) and STI screening guidelines (56%). Less than half of PCPs were aware of national TGD-specific HIV/STI testing guidance (48%). In multivariable analyses, having ≥ 6 h of training in TGD health (b=0.96, p<.01) and serving more TGD patients (b=0.81, p<.01) were significantly associated with self-reported clinical competency to assess a TGD person. Qualitative findings expanded upon quantitative findings, highlighting how gendered assumptions may influence provider testing recommendations in the absence of TGD-inclusive STI screening guidelines, and how a lack of formalized educational opportunities impede perceived competency, particularly in performing anal cytology for HPV-related cancer screening.ConclusionsFindings underscore the importance of training to improve equitable access to gender-affirming STI screening for TGD populations and mitigate barriers to sexual health equity.Clinical trial numberNot applicable.Keywords: Sexual health, Provider training, Medical education, Transgender, Non-binary, Sexually transmitted infections, Gender, Gender affirmation, Primary care, Continuing medical education Background The United States (U.S.) National Institutes of Health recognizes sexually transmitted infections (STIs) as a critical global health priority due to their devastating negative health impacts, especially if left untreated [1]. Transgender (trans) and gender diverse (TGD) persons are disproportionately affected by STIs [2–4]. Despite being routinely excluded from national data systems that conflate gender and sex, a recent meta-analysis drawing on 25 studies (eight U.S.-based) with laboratory-confirmed STI rates identified high prevalence of gonorrhea (trans men: 4–5%; trans women: 6–8%), chlamydia (trans men: 6–7%, trans women: 10%), and syphilis (trans men: 1–2%; trans women: 20%) among TGD persons [2]. Routine testing of non-HIV STIs is critical to the prevention of disease transmission and the reduction of health complications from untreated infection. The CDC recommends at least annual screening for chlamydia, gonorrhea, and syphilis among sexually active individuals [5], with adaptations for TGD persons, based on anatomy and sexual practices [5]. Despite this, TGD persons consistently face barriers to receiving sexual health care and, consequently, have clinically significant gaps in STI testing [6–11]. Studies among sexually active TGD people in the U.S. demonstrate suboptimal uptake of non-HIV STI testing relative to recommended guidelines, highlighting missed opportunities for prevention and care [6]. Primary care providers (PCPs) serve as a critical access point for STI testing, as they are often the first point of contact within the healthcare system and provide longitudinal, comprehensive care. As a result, PCPs play a central role in shaping access to sexual healthcare, including HIV/STI testing [12–14], and represent a key target for interventions to improve equity in care for TGD populations. Yet, STI testing with TGD communities may present unique challenges for PCPs, as it often involves detailed sexual history taking and potentially invasive physical examinations, which may exacerbate gender dysphoria or discomfort, particularly in the context of prior stigmatizing healthcare experiences [15]. Barriers to STI testing among TGD populations include limited provider knowledge and competency in gender-affirming care, as well as anti-trans and intersecting stigmas within healthcare settings [9, 15, 16]. These barriers contradict the guidance of leading organizations such as the American College of Physicians, which emphasize the provision of culturally competent, non-discriminatory, and affirming care for TGD populations [17]. Gender affirmation, defined as the recognition and support of a person’s gender identity [18–20], is a social determinant of health for TGD people [21] and has been associated with improved engagement in HIV/STI prevention, testing, and care [22]. Despite their central role, lack of access to comprehensive, competent, and gender-affirming sexual healthcare from PCPs remains a substantial barrier to the uptake of sexual healthcare, including HIV/STI testing among TGD persons. A growing body of literature demonstrates the feasibility and effectiveness of lesbian, gay, bisexual, trans, queer, and other sexuality and gender diverse people (LGBTQ+) diversity trainings, including improvements in provider attitudes, knowledge, and clinical skills [23–29]. Such interventions can increase knowledge of TGD health issues and comfort level working with TGD persons, while reducing stigma [30–38]. However, training on TGD-specific clinical needs remains limited in professional education programs, leaving PCPs underprepared to offer appropriate sexual health care. For example, less than half (45%) of medical students in one study felt they had received adequate TGD training before a targeted curriculum [39]. Thus, we aimed to understand the current practices, comfort, and knowledge gaps of PCPs in performing gender-affirming STI testing, particularly non-HIV STI testing, among TGD persons. Findings may inform the development of PCP educational interventions to increase access to gender-affirming sexual healthcare and enhance health equity among TGD communities. Methods Study design & setting We utilized a convergent parallel mixed-methods study design whereby quantitative cross-sectional survey data (n = 50 PCPs) and qualitative semi-structured interview data (n = 8 PCPs) were collected simultaneously, analyzed separately, and then integrated during analyses [40]. Survey data were collected from January to February 2024, and qualitative interviews were conducted from October 2024 to January 2025. A convergent parallel design was selected to allow for the concurrent collection of quantitative and qualitative data with equal priority, facilitating direct comparison and triangulation of findings across methods to better understand PCPs’ practices, knowledge, and training needs related to STI testing for TGD populations [40]. Participant inclusion criteria and recruitment Survey participation eligibility criteria included that participants: (1) be a PCP (inclusive of physicians, nurse practitioners (NPs), and physician assistants (PAs); (2) practice in the state of Michigan; (3) be 18 years of age or older; and (4) be able to complete an online survey in English. Participants were recruited via emails to four University of Michigan listservs for medical faculty, residents, nurse practitioners, physician assistants, and fellows in the Department of Family Medicine. The listservs included approximately 150 contacts, and emails were sent to each listserv twice. Potential qualitative participants were purposively sampled and contacted directly by SM, a third-year medical resident, via email. SM reached out to residents, fellows, and physicians who were known to deliver care to TGD patients. This purposive sampling approach was used to ensure that participants could speak directly to STI testing practices, challenges, and training needs in the context of TGD care. Additional qualitative participants were recruited using snowball sampling by asking participants at the end of the interview if they had any potential participants to recommend. All study procedures were approved by the University of Michigan Institutional Review Board, which subscribes to ethical guidelines outlined in the Belmont Report and the Declaration of Helsinki. Quantitative data collection Eligible participants received an electronic study information page and accessed the survey through Qualtrics, a Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant online survey platform [41]. The brief (20-minute max) survey assessed PCP sociodemographic characteristics (age, gender, race/ethnicity, sexual orientation, religion/spirituality), practice-related characteristics (professional role [physician, NP, PA], practice location [large city > 100,000 people, small city 10,000-<100,000 people, rural < 10,000 people], number of TGD patients served in the past year), past TGD-specific educational experiences (total hours of training ever received on any topic related to TGD health), awareness of guidelines for STI testing including general guidelines [CDC (5) and U.S. Preventive Services Task Force (USPSTF) [42] and TGD-specific guidelines [University of California, San Francisco (UCSF) Guidelines for the Primary and Gender-affirming Care of Transgender and Gender Nonbinary People [43] and the World Professional Association for Transgender Health (WPATH) Standards of Care, 8th Version [44]), and self-reported clinical competency to assess a TGD person (score ranging from 1, strongly disagree to 7, strongly agree), used as a proxy for overall gender-affirming clinical competency. Participants received a $20 Starbucks gift card for completion of the survey. Qualitative data collection Semi-structured individual 30-45-minute interviews were conducted over Zoom by SM, facilitated by an interview guide, after the participant reviewed the information page which had been sent to them via email. Interviews further explored how PCPs navigate sexual history taking/physical exam in the context of STI testing with TGD persons (e.g., “Please walk me through a typical experience taking a sexual history for a patient. Tell me about particular questions, if any, that you might ask when taking the history of TGD patient compared to a cisgender patient”), apply testing guidelines (e.g., “What STI guidelines do you routinely follow in the care of your patients? How do you apply these STI testing guidelines for your trans and gender diverse patients?”) and perceived gaps in their knowledge that they would like training on (e.g., “What areas would you like to receive more training in?”). The semi-structured interview guide was developed to align with the study aims and was informed by prior literature on gender-affirming care and provider training, as well as the research team’s expertise in TGD health and sexual healthcare. All interview participants were family physicians. Interview participants received a $40 Starbucks gift card for completion of the interview. Data analyses With respect to quantitative analyses, we first summarized all variables utilizing mean and standard deviation (SD) for continuous variables and frequency and proportion for categorical variables. We conducted bivariate analyses and multivariable regression modeling in Stata version 18 to determine sociodemographic, practice-related, and past educational experience factors independently associated with self-reported perceived competency to clinically assess a TGD person, measured continuously. Qualitative data were analyzed using open inductive coding via a directed qualitative content analysis approach whereby patterns were identified in response to specific areas aligned with the interview guide [45]. These included: approaches to STI screening and TGD-specific considerations, application of STI screening guidelines, past training experiences, gaps in training, and desires for future training, including modality and follow-up resources. HK initially coded the transcripts, then reviewed coding bi-weekly with ALD. HK and ALD met with SM, given content expertise, twice to receive input on interpretation of study findings. Finally, the full team reviewed the manuscript providing additional context and interpretation. Our interdisciplinary research team included health equity scholars, clinicians, and researchers with expertise in gender-affirming care and community-based research with TGD populations. The team included members who identify as nonbinary and queer, alongside clinicians with experience providing gender-affirming primary care. These perspectives informed the analytic approach, including the interpretation of findings through a gender-affirming and trauma-informed lens and attention to structural and practice-level barriers to STI testing. Mixed-methods analyses involved triangulation and integration of the two forms of data, allowing for an interpretation greater than individual qualitative and quantitative parts [46]. Specifically, we: (1) chose dimensions by which to compare results from quantitative and qualitative data (survey variables aligned with interview questions); (2) identified which information would be compared (e.g., comparing the proportion reporting use of general versus TGD-specific screening guidelines with narratives about the utility of such guidelines in practice); (3) completed refined analyses to produce information to compare as needed; and (4) represented comparisons through written descriptions, using a statistics-by-themes approach [47]. Results Survey participant sociodemographic characteristics Participants were a mean age of 38.7 (SD: 10.8) (Table 1). All were cisgender, and most were women (n = 40, 80%), heterosexual/straight (n = 45, 90%), non-Hispanic white (n = 38, 76%), and identified as not religious or spiritual (n = 30, 60%). Most were physicians (n = 46, 92%) practicing in small or large cities, with a few participants (n = 4, 8%) practicing rurally. Table 1Sociodemographic characteristics of primary care providers (N = 50)VariableMean (SD) or N (%)Age38.74 (10.78)Gender Cisgender woman40 (80%) Cisgender man10 (20%)Sexual orientation Heterosexual/straight45 (90%) Gay1 (2%) Bisexual4 (8%)Race and ethnicity Non-Hispanic white38 (76%) Non-Hispanic Black or African American1 (2%) Hispanic white2 (4%) Prefer not to share1 (2%)Religious/spiritual Yes19 (38%) No30 (60%) Missing1 (2%)Professional role Physician46 (92%) Nurse practitioner3 (6%) Physician assistant1 (2%)Practice location Large city17 (34%) Small city29 (58%) Rural area4 (8%) Sociodemographic characteristics of primary care providers (N = 50) Focal areas of mixed methods exploration Results are organized into five focal areas: (1) approaches to STI screening and TGD-specific considerations; (2) application of STI screening guidelines; (3) past training experiences and association between past training and self-reported clinical competency; (4) gaps in training; and (5) desires for future training (modality and follow-up resources). The first focal area presents qualitative findings, while subsequent sections integrate both qualitative and quantitative data where applicable. Exemplary quotes are presented throughout with additional quotes in Table 2. Table 2Exemplary quotes from PCPs (n = 8)Focal AreaExemplary QuotesApproaches to STI Screening and TGD-specific Considerations“I think I like more specifically ask about sites of potential exposures for trans and non-binary and LGBTQ+ folks in general, because I again, I want to know more about their sites of exposure for potential screening purposes.” (P3)“So I am very sensitive to anyone who doesn’t want to have an exam, but in particular, [for] my for my transgender patients who have a uterus and cervix still, and is like really, not even at risk or yeah, and just don’t want to do it. So, this is where the self-swab is going to come into effect.” (P4)“Because of what the potential issues are with dysphoria for our patients who are gender, transgender or gender diverse I do try to be a little bit more cautious about screening or if I need to do an exam. but that’s really the only time I’ll need to I’ll be, I’ll think it’s any different than for a cisgender person.” (P6)Application of STI Screening Guidelines“I feel like it’s hard for me to cite specific guidelines. I would say, like USPSTF generally recommends annual STI screening at least. And then, if people have new partners I would say, the other thing where it comes into play is folks who are on PrEP. We typically like rescreen them every 3 months, at least.” (P3)“Yeah, not really [do I follow any specific STI screening guidelines]. And then I mostly, you know, just like reading all like the UCSF. I mean, I feel like I just like glued myself to the UCSF guidelines my 1st year out of Residency. And like, really learned those or the Fenway guidelines.” (P7)Past Training Experiences“I went to a medical school that was very like progressive and they did a really good job at ensuring that we were taught during our endocrinology block about trans, and like hormone replacement therapy. One of the endocrinologists was like really big on hormone replacement therapy and trans patients…. And we did like breakout groups with trans patients. So I feel like medical school was a good place for that. And then Residency has been a really good place for that, just because a lot of providers are very open to providing the care. And we go to different sites where we do trans care specifically.” (P1)“Well, in Med school, I like I did a couple of educational lectures for my colleagues. And I was split pretty 50–50 between cultural competency, just knowing how to work with these populations and information about like gender affirming hormone therapy and about minority stress model, like differing mental health risks, things like that. I did some teaching on that again in Residency which I do think is needed and is helpful…. We talked somewhat about sexual health but I didn’t get into the details of like… very much of the screening other than the I have encountered patients who had trouble getting screened for syphilis, so at the very least letting people know. But if you have a patient who is asking for syphilis screening, that you should give it to them. But I don’t think I got very far into the details of what to screen for, and when in which populations.” (P5)Gaps in Training“There isn’t really like a strong guideline of when to do like anal Paps [Papanicolaou testing] or anal HPV screening.” (P3)“Oh, yeah, like, even how to take a history for someone that is gender non-conforming…. I think that we need a lot more training around gender affirming health care in primary care. And like when there’s a reason, endocrinology exists, and so like what would be indications to refer. And also like, here’s how at baseline you could at least like collect all the necessary, like the right kind of information, to help guide your treatment, because I think part of this is like pronouns and body parts, and like organ inventories, and like language, mirroring and harm reduction.” (P8)Desires for Future Training (Modality and Follow-up Resources)“I feel like it would probably be a good thing for Grand Rounds, especially like the hormone follow-up and doing like case discussions. I feel like that would be a good setting for our in-person didactics to kind of help with discussion. So, people can also ask questions about like, why they would recommend managing it a certain way.” (P3)“I think, like workshops where you work through cases would probably be helpful. workshops where you work through cases like through language, like practicing with someone that does this around like demeanor, language, physical exam, like that kind of stuff. But then I think, like for the medical stuff, like, I think, yeah, like, I think it’d be really helpful to do like practice scenarios. I don’t necessarily think it like you could maybe an online module like something like that. But I do think that there’s some value in doing this like in getting real time feedback.” (P8) Exemplary quotes from PCPs (n = 8) “I think I like more specifically ask about sites of potential exposures for trans and non-binary and LGBTQ+ folks in general, because I again, I want to know more about their sites of exposure for potential screening purposes.” (P3) “So I am very sensitive to anyone who doesn’t want to have an exam, but in particular, [for] my for my transgender patients who have a uterus and cervix still, and is like really, not even at risk or yeah, and just don’t want to do it. So, this is where the self-swab is going to come into effect.” (P4) “Because of what the potential issues are with dysphoria for our patients who are gender, transgender or gender diverse I do try to be a little bit more cautious about screening or if I need to do an exam. but that’s really the only time I’ll need to I’ll be, I’ll think it’s any different than for a cisgender person.” (P6) “I feel like it’s hard for me to cite specific guidelines. I would say, like USPSTF generally recommends annual STI screening at least. And then, if people have new partners I would say, the other thing where it comes into play is folks who are on PrEP. We typically like rescreen them every 3 months, at least.” (P3) “Yeah, not really [do I follow any specific STI screening guidelines]. And then I mostly, you know, just like reading all like the UCSF. I mean, I feel like I just like glued myself to the UCSF guidelines my 1st year out of Residency. And like, really learned those or the Fenway guidelines.” (P7) “I went to a medical school that was very like progressive and they did a really good job at ensuring that we were taught during our endocrinology block about trans, and like hormone replacement therapy. One of the endocrinologists was like really big on hormone replacement therapy and trans patients…. And we did like breakout groups with trans patients. So I feel like medical school was a good place for that. And then Residency has been a really good place for that, just because a lot of providers are very open to providing the care. And we go to different sites where we do trans care specifically.” (P1) “Well, in Med school, I like I did a couple of educational lectures for my colleagues. And I was split pretty 50–50 between cultural competency, just knowing how to work with these populations and information about like gender affirming hormone therapy and about minority stress model, like differing mental health risks, things like that. I did some teaching on that again in Residency which I do think is needed and is helpful…. We talked somewhat about sexual health but I didn’t get into the details of like… very much of the screening other than the I have encountered patients who had trouble getting screened for syphilis, so at the very least letting people know. But if you have a patient who is asking for syphilis screening, that you should give it to them. But I don’t think I got very far into the details of what to screen for, and when in which populations.” (P5) “There isn’t really like a strong guideline of when to do like anal Paps [Papanicolaou testing] or anal HPV screening.” (P3) “Oh, yeah, like, even how to take a history for someone that is gender non-conforming…. I think that we need a lot more training around gender affirming health care in primary care. And like when there’s a reason, endocrinology exists, and so like what would be indications to refer. And also like, here’s how at baseline you could at least like collect all the necessary, like the right kind of information, to help guide your treatment, because I think part of this is like pronouns and body parts, and like organ inventories, and like language, mirroring and harm reduction.” (P8) “I feel like it would probably be a good thing for Grand Rounds, especially like the hormone follow-up and doing like case discussions. I feel like that would be a good setting for our in-person didactics to kind of help with discussion. So, people can also ask questions about like, why they would recommend managing it a certain way.” (P3) “I think, like workshops where you work through cases would probably be helpful. workshops where you work through cases like through language, like practicing with someone that does this around like demeanor, language, physical exam, like that kind of stuff. But then I think, like for the medical stuff, like, I think, yeah, like, I think it’d be really helpful to do like practice scenarios. I don’t necessarily think it like you could maybe an online module like something like that. But I do think that there’s some value in doing this like in getting real time feedback.” (P8) Approaches to STI screening and TGD-specific considerations Participant narratives indicated similarities in how PCPs conducted routine STI testing for their patients irrespective of gender, and by and large identified the use of best-practice gender-neutral organ-based screening similarly among both cisgender and TGD patients. Really [I don’t] even recall anything about STI screening that’s any different. Because, again, why don’t we just do it based upon the organ? So why, would it be any different [between cisgender and TGD patients]? (P4) Usually, when I meet a patient for the first time, for anything sexual health or [reproduction] related, I have a conversation with them about what kind of language they want me to refer to their body parts as and what kind of language they want me to refer to. I maybe pay more attention to it if I know that the patient is gender nonconforming, or trans. But not, it’s not like something that I would necessarily do differently. (P8) While this was routine for most providers, some others described framing questions differently for TGD people compared to cisgender people, such as completing a more specific body inventory and asking more nuanced sexual practice questions, as this provider shared: So, I am probably more likely to ask body part inventory questions of my patients who are nonbinary or trans and my counseling really depends on what activities they’re taking part in. Because it will be specific to like, are we having oral intercourse? Are we having anal intercourse? Are we having vaginal? Are we receptive? Are we penetrating? What risk level are we? What risk level do I need to counsel for? (P5) For others, the use of more inclusive language was guided by assumptions about sub-group familiarity and comfort with such use (e.g., TGD people, adolescents), as these participants shared: I would say, for nonbinary or trans folks I tend to use, “How do your partners identify” or ask more specifically, “Are you sexually active with any partners who produce sperm?” to get a little bit more at what types of sex they’re having. I do find that sometimes, cisgender or like people who identify as straight or heterosexual, don’t really understand the question of how does your partner identify, or does your partner produce sperm? So that’s why I sometimes use differing language. (P3) I would say, generally, still asking the same questions [irrespective of gender], I will sometimes frame them a little differently [for adolescents]. I tend to like, ask them like, do you have sex with anyone who produces sperm as like a way to kind of sound, to be more inclusive, but also asking about pregnancy potential. Whereas, like I don’t tend to frame it that way if it’s a cis woman. (P2) Another routine practice that participants discussed was the use of trauma-informed principles in sexual healthcare. I always open with like asking for consent before I talk to my patients about anything, but especially things that like may be triggering, so I usually ask for permission to ask about more personal matters, and then I always ask about if any of this is triggering, or you have any sort of trauma related to it. Please feel free to correct my language. And or opt out of this completely it’s totally okay. (P8) Many providers mentioned their use of self-swabbing when screening for STI testing with their TGD patients, particularly when concerned about body dysphoria during physical examination and/or past trauma. And it’s not specific to transgender people again. I guess if there’s something I need to know that I should be doing drastically differently. You know, trauma-informed care, taking care of people’s the organs that they have. Yeah, you know, making use of non-invasive testing. (P4) Providers mentioned more frequent STI screening in the context of pre-exposure prophylaxis (PrEP) use for HIV prevention. Some gendered assumptions were noted around STI prevention and testing: I offer like PrEP to all my like trans women, because, like that group is like so high for a risk of like HIV acquisition. (P2) I definitely do it [bring up STI testing], or at least talk about it with my patients, who are HIV positive. And men who have sex with men. Although, for I would say, especially for cis women, but also, I would say, like trans men, it doesn’t come up quite as often because I think the assumption is made that they’re primarily having vaginal sex. (P3) P3’s quote reflects how provider assumptions about sexual practices and perceived risk may shape STI testing practices. While participants described prioritizing HIV/STI discussions with patients perceived to be at higher risk (e.g., men who have sex with men), these assumptions may contribute to under-screening among individuals engaging in vaginal sex, including cisgender women, trans men, and nonbinary persons assigned female at birth, who remain at risk for HIV and other STIs. Application of STI screening guidelines Survey participants were asked about their awareness of specific HIV/STI testing guidelines, including general guidelines from the CDC, USPSTF and TGD-specific guidelines. Of these guideline sources, a majority of respondents were aware of the USPSTF (96%) and CDC (82%) and a minority were aware of the UCSF (48%) and WPATH (26%) guidelines. Participants also reported that they most often used the USPTF guidelines (38%) followed by the CDC (32%) and UCSF guidelines (16%). No respondents in the quantitative sample reported using the WPATH guidelines. Qualitative findings echoed quantitative results in that participants most often mentioned USPSTF and CDC guidelines for general resources, expanding on TGD-specific resources beyond UCSF to include Fenway Health. Participant narratives revealed the complexity of navigating STI testing guidelines amidst a shifting landscape and available knowledge, particularly around TGD health, and piecing together multiple guidelines: So, most of our guidelines we use for our transgender health is going to be through UCSF or Fenway Health, and they follow a lot of the newer guidelines that we do for questioning, but also for screening. And then I also use CDC as they tend, they tend to change the guidelines for treatment more regularly. (P6) Participants reflected on the difficulty of navigating guidelines, specifically when seeing TGD patients and more specifically TGD patients who have had gender-affirming surgeries. Some of what I want is stuff that I don’t think actually exists. I want USPSTF recommendations for preventive health screenings for my trans patients, instead of having to guess whether to apply male or female, or for which particular complaints. (P5) [There are gaps in USPSTF and CDC guidelines] especially for patients who are post-bottom surgery. I don’t really know which guidance to go off of. (P5) Past training experiences and association between past training and self-reported clinical competency Most quantitative participants received training in discussing sexual healthcare with TGD people (92%) and just over half (54%) of participants reported receiving six or more hours of training on topics specific to TGD healthcare. Participants also reported having provided services in the past year to 0–5 TGD patients (22%), 6–20 TGD patients (58%), and 21–50 TGD patients (20%). Finally, when asked the extent to which they agreed that “I feel competent to assess a person who is transgender in a clinical setting,” no participants strongly disagreed, 3 (6%) disagreed, 3 (6%) somewhat disagreed, 3 (3%) neither agreed nor disagreed, 12 (24%) somewhat agreed, 24 (48%) agreed, and 5 (10%) strongly agreed. In separate bivariable regression analyses, receiving 6 or more hours of training and number of TGD patients were each significantly associated with self-reported clinical competency to assess a TGD person (β = 1.32, p<.001, F(1,48) = 17.43, p<.001; β = 1.06, p<.001, F(1,48) = 19.95, p<.01, respectively). In multivariable analysis including both variables, hours of training (β = 0.96, p<.01) and number of TGD patients (β = 0.81, p<.01) were each independently associated with self-reported clinical competency, accounting for 39% of variance (Adjusted R2) in the outcome (F2,47 = 16.82, p<.001) (Table 3). Receiving six or more hours of training was associated with nearly one higher level of agreement in self-reported clinical competency than those with fewer than six hours of training. Likewise, having more TGD patients (such as 6–20 patients vs. 0–5 patients) was associated with a 0.81 increase in agreement in self-reported clinical competency to assess TGD patients. Results indicate that more training and serving more TGD patients are associated with self-reported clinical competency. Multivariable results are presented in Table 3. Table 3Multivariable regression on self-reported clinical competency to assess TGD patientsVariableβ p Hours of training0.960.01Number of trans and gender diverse patients0.810.01F(2,47) = 16.82, p<.001, Adj R2 = 0.39 Multivariable regression on self-reported clinical competency to assess TGD patients F(2,47) = 16.82, p<.001, Adj R2 = 0.39 Those PCPs who were interviewed had a diversity of educational experiences throughout their medical training. Participants discussed the nuances of different forms of training (e.g., hands-on) and different levels of experience (from medical school through residency): I don’t think Med school was not useful. I think it’s just harder to contextualize the nuances of meds and stuff until you are in residency training. All of the trainings we’ve had in residency so far, have been really helpful, but actually working with providers is definitely the most helpful, because there’s things that I hadn’t even thought about until I started working with them. (P1) Many participants echoed the importance of residency training: I would say I’ve had almost no trainings, you know, I would say the majority of my learning experience was rotations that I did in residency. (P2) Thus, for these PCPs their training in TGD care was contingent upon initiatives/will of the residency program(s) and particular champions of TGD health within the program: We got like a decent amount of training in my residency, like through specific providers like we had several workshops around this and then I did like some stuff through [community-based sexual and reproductive health organization] …. I did an online training through some organization that I can’t remember the name of… And then a lot of the stuff that I learned is actually through like the [TGD health listserv]. So that’s where I have learned, like most of the like, most of the stuff. (P8) This quote also exemplifies another key finding, that many PCPs must take on the initiative to learn on their own accord. Some PCPs discussed the medical necessity of receiving additional teachings or training outside of their trusted medical training institution because of their lack of education on providing TGD affirming healthcare, ultimately requiring additional time and financial investment, with still gaps in knowledge: It’s more self-guided. And then we had, like a couple of talks during Residency. I think, like the challenges I’ve had coming out of that curriculum like I feel relatively comfortable with hormone starts. I think. The challenge is [hormone] adjustments. (P3) Gaps in training Quantitative participants were asked which topics pertaining to TGD healthcare they would like to receive more training on. More than half of respondents reported that they would like to receive more training on gender-affirming sexual history taking (62%), basic understanding of TGD healthcare such as gender-affirming hormone therapy (60%), STI screening (56%), patient-centered prevention and counseling (56%), gender-affirming physical examination (54%), and affirming words to discuss gender identity and expression (54%). Upon gaining more conclusive information from providers interviewed, there were many gaps in medical training and clinical areas that not all medical providers were receiving throughout the course of their education. Some notable training and guidance on aspects to TGD healthcare that providers were not receiving include mental health among TGD people, voice therapy, prescribing and adjusting gender-affirming hormones, gender-affirming surgeries, performing anal Pap exams, and managing medical care long-term for TGD patients. As this participant shared: I do kind of wish we had more familiarity with gender-affirming care outside of hormones, because I do feel a lot of times patients have questions about gender-affirming surgery or voice therapy that I don’t know always how to answer. (P3) A concern among several providers was limited or no knowledge on anal cytology/anal Paps. If providers did receive medical training on performing anal Paps, they considered themselves “lucky” to have received this “rare” training. I would say one gap that I wish there was more consensus on is HPV screening, anal Paps and anal HPV screening. It’s still kind of one of those we think you should do it but we don’t know yet… So that’s that I would probably say, that’s the one I think I need it needs to be more of. (P6) Additionally, many providers described their lack of comprehensive medical training on basic preventative care measures and finding practical solutions to treat patients with different organ presentations, with a concern for the future of reproductive healthcare more broadly. As this participant shared: I think something I didn’t get a ton of training in that would have, and probably I could read up on it, too, but just like the like guidelines that are evolving around preventive care…. We have kind of like loose guesses about when to start mammograms, you know, in a patient on estrogen. But I’m sure that will change as we learn more. So, the preventive care stuff, I think would be great like for initial training and for ongoing training. (P7) Providers stressed the importance of basic training on gender-affirming care and the assumption that this is part of primary care: There shouldn’t be specific doctors who do gender-affirming care only, like we should all be doing it because [it is] part of primary care. (P6) I inherited a panel of probably like 30 or 40 trans patients at that clinic and then built it from there. So, I just got a lot of like on the fly teaching from people there [at the clinic] where it was just assumed that if you were a provider there you had trans patients it wasn’t like, “Oh, you’re the gender-affirming hormone person. It was just like, “Here you go. You manage diabetes, and you do prenatal care and you do gender-affirming care” like no question. (P7) Beyond the clinical considerations, others emphasized the need for training that focused on stigma and discrimination, its negative impacts, and basic TGD inclusion: I’ve had trainings relate[d] to like repro[duction] needs. But, not like sexual, not like STI-related trainings. And yeah, I do think it could be helpful. I think it’d be helpful around language…. And I think, like, helping folks see that like healthcare can be a traumatic space, and that you can still practice like good medicine, and, you know, mitigate harm in a way that can serve like folks that are intersectionally marginalized. I think that that type of stuff could be helpful in these types of trainings. (P8) Desires for future training (modality and follow-up resources) Many providers reflected on what type of format would accommodate themselves and other providers who need additional training on providing affirming and intersectional STI care for TGD people, as well as what follow-up resources would be helpful. Providers interviewed had differing perspectives on formats they would prefer to engage in for additional training in regard to TGD healthcare. Some PCPs preferred the idea of having in-person training sessions, where they could talk through specific cases with more experienced professionals. Others preferred virtual training sessions, mainly because of time constraints, financial disincentive, or personal learning preferences. So, if it was like something for CME [continuing medical education]. That was like part of you know, like our Grand Rounds, or something like that. But no preference in terms of like virtual or in-person. (P2) I always love things that are in person, but they are so impractical, often forgetting, you know, larger audiences to engage and attend. I think asynchronous to me it feels more practical. And that more people, might actually pay attention to them…. Asynchronous when I do any of my learning outside of work time. It’s listening or watching a lecture. (P7) Regardless of the format of training, all providers agreed on the necessity of additional trainings on TGD healthcare topics ongoing for their professional development. In terms of follow-up resources, one specific suggestion was to have short references that providers could look back on after participating in a training session, which would ensure that providers have the essential information needed to screen TGD patients that they can constantly revisit, if needed: I do think there is value in having like something you can go back and reference later, whether it’s slides or like materials, in a self-directed course. Or even think like, if it could count towards like elective time, or something like that. (P3) Sheets just cheat sheets like literally anything like that. (P4) Additionally, interviewed providers supported the idea of obtaining clinical references to other aspects of gender-affirming care, including (but not limited to) how to prescribe hormones, changing hormone prescriptions based on side effects, and developing specific gender-affirming care treatment plans. PCPs thought that specific case examples would be most helpful: And I do think it’d be helpful to have like case examples of follow-up. So, for example, you’re seeing a trans woman for follow-up, and she has been on estrogen and spironolactone for this long and she’s unsatisfied with her breast development. What could you do next? So, like examples like that of how to manage it. Cause I feel like that’s where it becomes more challenging. (P3) Some interviewed providers focused on accessing additional medical advice from other experienced providers who specialize in gender-affirming care. Some providers mentioned their success in TGD healthcare based on having a single professional with more experience and that they consult in the event they ran into a problem with TGD treatment for a patient. I think the most helpful thing…instead of getting lectured on stuff, we just asked them [a well-trained expert] all of our questions, because at this point, we’ve all like encountered trans patients in our clinics…. So, what would be helpful is like someone answer all these like random little questions that we have…. (P1) Finally, a few participants remarked on organizational-level interventions that may support their ongoing provision of gender-affirming sexual healthcare, such as smart sets. A smart set is a “combined documentation, decision and inquiry-support tool that can group multiple pre-filtered functions for a more efficient and error-free charting workflow” [48]. Having smart sets that are already created for providers to reference TGD sexual health care seemed to interest many providers. Similar to a medical reference, providers described how they could utilize smart sets by going back to them in the event that they encountered a situation they are unfamiliar with. One thing that I had at my previous institution, was a smart set that would basically have the right test order based on what the questions you may have asked were, and also what specimen what location of the swab you would order. You plug it all in it, you know, with different separate orders. I used to have a colleague of mine who’s older and didn’t know what he was doing half the time and he would just like pull up the smart set and order the right tests cause it’s all basically handed to him like, this is how you order it. (P6) One participant was eager for these organizational changes and created their own template in their electronic health record to capture needed inclusive information: One of the things I’ve started doing new was creating a different template [in my electronic medical record system]. I’m going to start over with all of my patients and confirm gender identity and sexual orientation…. Now I’m putting it into my [files] and annual exam. And I’m just saying to everybody, I know I’ve never really formally asked you this before but I’m going to be asking everybody from now on. (P4) Discussion Drawing on a sample of PCPs in a Midwestern U.S. state, our study documented practices, comfort, and knowledge gaps in providing gender-affirming STI testing, particularly non-HIV STI testing, among TGD people. Findings inform PCP educational interventions to increase access to gender-affirming sexual healthcare and enhance health equity among TGD communities. We contextualize key findings within three key implications: (1) there is a need to institutionalize gender-affirming sexual healthcare and medical gender affirmation, particularly gender-affirming hormone therapies, in medical education and residency programs; (2) more specific STI screening guidelines are needed from leading LGBTQ+/TGD health organizations, including pertaining to anal cytology; and (3) in the interim to these structural changes, PCPs can draw on existing best practices of trauma-informed and non-gendered/gender-inclusive sexual health screening. Clinical decision support tools, such as electronic health record “smart sets” (pre-configured order panels and documentation templates), may further support providers in delivering gender-affirming STI testing by providing evidence-based recommendations at the point of care and reducing cognitive burden. However, such tools are typically developed at the institutional level and require integration within specific electronic health record systems, as well as alignment with local workflows and governance structures [49, 50]. Limited interoperability across systems and challenges with clinician uptake may further constrain their broader scalability. Practical approaches such as urine-based testing and self-swabbing offer non-invasive options for STI screening [51]. Qualitative studies show that TGD people and providers recognize that having the option to self-swab for STI testing may mitigate potential gender dysphoria/distress induced by physical examination [16, 52]. Systematic reviews demonstrate that self-collected samples are comparable to provider-collected specimens across STIs [53, 54], and studies among TGD populations show high acceptability [55, 56] and strong agreement with clinician-collected samples [57]. Prior community-based research highlights the importance of trauma-informed care principles including safety, trust, collaboration, choice, and empowerment [58] throughout the entire process of taking a sexual history, physical examination, and STI testing [15]. Our study findings may guide providers in how to actualize such principles (e.g., an improved informed consent process) [15]. Despite increasing attention to TGD health education, training remains limited across medical education and residency programs [59–61]. For example, findings from a scoping review examining LGBTQ+ health inclusion in U.S. medical residency programs showed that physicians reported an average of 4.98 h and 3.18 h of didactic residency training related to cisgender gay men and lesbian women’s health, respectively, and only 1.28 h related to trans health [59]. Even among our relatively highly trained sample, participants reported persistent gaps and ongoing training needs, particularly related to STI testing. Our study participants still desired more training on a myriad of topics related to both sexual health and gender-affirming healthcare, with some also noting the importance of integrating systemic considerations into such training (e.g., intersectionality). These findings are particularly relevant to STI testing, where gaps in training may directly affect providers’ ability to conduct an affirming sexual history, determine appropriate anatomical screening sites, and implement guideline-concordant sexual healthcare for TGD patients. Our finding that the number of hours of training PCPs receive is statistically significantly and independently associated with self-perceived comfort to clinically assess a TGD person is consistent with a plethora of studies underscoring the efficacy of training interventions to improve knowledge and reduce stigma [30–38]. This is especially critical in the context of STI testing, which requires both clinical competency and comfort navigating sensitive, and at times invasive, aspects of care. Training may be strengthened through the use of clinical “champions” [62], with those who represent TGD communities in their identities and/or with a longstanding history of advocacy/activism and entrenched trustworthiness with TGD communities being particularly effective in the role [63]. Many participants in our study discussed how training should involve the use of case studies/practice scenarios, consistent with an active learning approach [64, 65]. That said, any training developed should consider a multi-modal approach to recognize different learning needs and availabilities. Of critical importance, some participants suggested that gender-affirming hormone therapy be routine in medical education. Integrated medical gender affirmation, including gender-affirming hormone therapy and HIV/STI prevention, testing, and care is shown to improve both non-HIV STI care outcomes as well as STI health outcomes [66, 67]. For example, Pletta et al. [67] found that gender-affirming hormone therapy was associated with statistically significantly higher odds of chlamydia and gonorrhea screening among TGD patients (aOR = 1.25, 95% confidence interval [CI] = [1.05, 1.49]). In another study, Reisner et al. [66] found that gender-affirming hormone therapy prescription was associated with a statistically significant reduction in the risk of an anogenital STI diagnosis (adjusted risk ratio = 0.75; 95% CI = 0.59–0.96). Apart from this compelling evidence about the importance of integrated STI and gender-affirming medical care, gender affirmation more broadly is a social determinant of health for TGD people [21] and gender-affirming medical care is life-saving for those who desire it [68]. Our participating providers indicated they would like more information about when it is appropriate to engage specialist care for TGD health, suggesting potential willingness to take on more gender-affirming medical care themselves. These findings underscore the importance of integrated care models, as engagement in gender-affirming care may also facilitate access to STI testing and other sexual health services. While most participants did not indicate the need to address TGD and cisgender people differently in the context of STI screening, espousing a preference to undertake inclusive approaches to sexual history taking among all patients, participants did also note a lack of TGD-specific STI screening guidelines as embedded within highly-recognized sources (e.g., USPSTF, CDC). Our findings also highlight how assumptions about sexual practices and perceived risk may shape clinical decision-making, potentially contributing to differential screening practices and inequities in STI testing for trans men and nonbinary persons assigned female at birth. Access to TGD-inclusive global guidelines from USPSTF and CDC have only worsened in the past six months, as these organizations are under the purview of the U.S. federal government and subject to their anti-trans assaults. Less than half of the sample reported awareness of TGD-specific healthcare guidance sources (e.g., UCSF, WPATH), although this measure reflects self-reported awareness rather than depth or familiarity of use. Qualitative participants noted that these sources were sparse in their description of STI testing guidance. The current sociopolitical context may necessitate these organizations to take a leadership approach to sharing more specific TGD inclusive sexual healthcare guidance, given a lack of national will for TGD inclusion. As there will be a lack of TGD health and particularly HIV/STI research in the coming years as a result of the cancellation of federally funded grants [69], guidance should be made based on what we know to-date. Participants identified gaps in training related to anal cytology, an area with limited guidance and evolving evidence. Human papillomavirus (HPV), the most prevalent STI worldwide, has several high-risk types that are causal to cancers, including anal squamous cell carcinoma (anal cancer) [70]. While there are no known studies documenting anal cancer prevalence among trans women, one study conducted among a small U.S.-based cohort of trans women living with HIV (n = 22) reported rates of anal dysplasia and abnormal histology comparable to cisgender gay, bisexual, and other men who have sex with men; specifically, anal cytology was abnormal among 95% of trans women [71]. There is also some evidence to suggest that estrogen increases HPV-related carcinogenesis, meaning trans women taking gender-affirming hormone therapy may be at increased risk of HPV-related cancers [72]. The 2023 International Anal Neoplasia Society’s consensus guidelines for anal cancer screening recommended screening initiation at age 35 years for trans women with HIV and age 45 for trans women without HIV [73]. Therefore, our participants indicated gap in anal cytology training and comfort conducting is of critical importance. Importantly, beyond gaps in guidance, implementation of anal cancer screening is further constrained by limited access to follow-up procedures such as high-resolution anoscopy, which is required to evaluate abnormal results and is not widely available in many settings [74]. More research is needed to understand the implementation of these guidelines both in clinical training and care. This study is limited by overall considerations (small sample size; participant selection bias), as well as limitations related to both quantitative and qualitative methodologies. Though the sample size was small at 50 quantitative participants and 8 qualitative participants, our confidence in the findings is enhanced through: (1) our use of mixed methods which allowed for data triangulation; (2) that 50 participants constituted almost one-third of the listserv from which we recruited for the quantitative arm (demonstrating a high response rate); and (3) we neared data saturation in the qualitative arm. It is likely that those who completed the study had more interest in TGD health than their peers who did not complete the study. Despite the uniformity in our sample (e.g., highly trained in one integrated health system), we were still able to identify statistically significant quantitative findings with respect to associations between the clinical context and training opportunities of providers, suggesting no ceiling effect. Our providers identified that they still had more to learn, consistent with a cultural humility approach [75]. We did not collect detailed sociodemographic characteristics for qualitative participants, limiting our ability to contextualize quotations (e.g., by age or provider role). Additionally, all qualitative participants were family physicians, which may limit the transferability of findings to other primary care provider groups (e.g., nurse practitioners, physician assistants). Finally, qualitative participants were purposively sampled based on their experience providing care to TGD patients; therefore, findings may not capture the perspectives of PCPs who do not provide care to this population, who may face distinct barriers to care provision. With respect to the quantitative arm, our study is primarily limited by cross-sectional analyses, which preclude causality. The primary quantitative outcome of self-reported clinical competency to assess a TGD person captures general gender-affirming clinical competency and is not specific to sexual healthcare/STI testing. As such, it may not fully reflect provider competency in delivering STI-specific services. We collected these data amidst an escalating anti-trans sociopolitical context, but before the 2024 presidential election, since which there have been several executive orders limiting access to gender-affirming healthcare and further threatening the human rights and safety of TGD communities [76, 77]. Future studies should explore how interest in/sense of safety delivering affirming care has changed since these political actions and assess providers’ desire for advocacy in the current context. Studies have documented the chilling effect of anti-abortion policy and secondary abortion stigma on abortion providers [78]. This same effect needs to be studied with gender-affirming healthcare providers [79]. Conclusion Our study highlights significant gaps in PCPs’ knowledge, comfort, and practices surrounding gender-affirming non-HIV STI testing, even among a relatively highly trained sample. These findings underscore the urgent need to integrate gender-affirming sexual health education, including medical gender affirmation and trauma-informed approaches, into medical training and clinical practice. Clearer, TGD-inclusive STI screening guidelines from leading health organizations are also warranted to guide providers. Addressing these gaps is essential to advancing equitable, affirming, and evidence-based sexual healthcare for TGD people. Abbreviations Adjusted odds ratio Centers for Disease Control and Prevention Confidence interval Human immunodeficiency virus Lesbian, gay, bisexual, trans, queer, and other sexuality and gender diverse people Nurse practitioners Physician Assistants Pre-exposure prophylaxis Primary care providers Sexually transmitted infections Transgender (trans) and gender diverse University of California, San Francisco United States U.S. Preventive Services Task Force World Professional Association for Transgender Health Author contributions Study Conceptualization – ALD, SM; Methodology – ALD, SM, JB; Formal analysis – RPO, HK, ALD; Investigation – SM; Writing – Original Draft – ALD, RPO, HK; Writing – Review & Editing – ALD, SM, SKK, RPO, HK, JB; Funding acquisition – ALD, SKK. All authors approved the final manuscript. Funding This study was funded through discretionary funding from the University of Michigan School of Social Work and a grant from the Curtis Center for Health Services Research and Innovation, University of Michigan School of Social Work. Data availability The datasets generated and/or analyzed during the current study are not publicly available due to the sensitive nature of data focused on trans and gender diverse communities but may be made available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate All participants provided informed consent. Study procedures were approved by the University of Michigan Institutional Review Board #HUM00240868, which subscribes to ethical guidelines outlined in the Belmont Report and the Declaration of Helsinki. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets generated and/or analyzed during the current study are not publicly available due to the sensitive nature of data focused on trans and gender diverse communities but may be made available from the corresponding author upon reasonable request.